FAF could be a useful tool for SC and SLC

Article

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC).

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC), according to a paper published in the journal Eye.

Dr E. Carreno et al., Department of Ophthalmology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain, conducted a prospective case series on 12 patients with SC and SLC. All patients experienced FAF imaging from July 2009 to December 2010.

There was bilateral involvement in nine cases and three different FAF imaging patterns were revealed. This included active inflammation, transitional and inactive inflammation.

FAF can be a helpful tool for imaging SC and SLC patients and it may be possible to reserve other invasive technique. For example FA could be used for patients with suspicious activity disclosed by FAF imaging.

The abstract can be found here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.